These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32526288)

  • 1. Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines.
    Uehara IA; Soldi LR; Silva MJB
    Life Sci; 2020 Sep; 256():117921. PubMed ID: 32526288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis.
    Fischer V; Haffner-Luntzer M
    Semin Cell Dev Biol; 2022 Mar; 123():14-21. PubMed ID: 34024716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
    Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
    FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular interactions between immune system and bone.
    Grcević D; Katavić V; Lukić IK; Kovacić N; Lorenzo JA; Marusić A
    Croat Med J; 2001 Aug; 42(4):384-92. PubMed ID: 11471190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone and calcium metabolism in menopause transition].
    Terauchi M
    Clin Calcium; 2011 Sep; 21(9):1353-9. PubMed ID: 21881198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss.
    Brunetti G; Storlino G; Oranger A; Colaianni G; Faienza MF; Ingravallo G; Di Comite M; Reseland JE; Celi M; Tarantino U; Passeri G; Ware CF; Grano M; Colucci S
    J Pathol; 2020 Apr; 250(4):440-451. PubMed ID: 31990039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency.
    Sato T; Shibata T; Ikeda K; Watanabe K
    J Bone Miner Res; 2001 Dec; 16(12):2215-21. PubMed ID: 11760834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen regulation of immune cell bone interactions.
    Weitzmann MN; Pacifici R
    Ann N Y Acad Sci; 2006 Apr; 1068():256-74. PubMed ID: 16831927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 7 and estrogen-induced bone loss.
    Ross FP
    Trends Endocrinol Metab; 2003; 14(4):147-9. PubMed ID: 12714270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
    Pacifici R
    J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of T cell-dependent and RANKL-dependent osteoclastogenic processes associated with high levels of bone mass in interleukin-15 receptor-deficient mice.
    Djaafar S; Pierroz DD; Chicheportiche R; Zheng XX; Ferrari SL; Ferrari-Lacraz S
    Arthritis Rheum; 2010 Nov; 62(11):3300-10. PubMed ID: 20617528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and the skeleton.
    Khosla S; Oursler MJ; Monroe DG
    Trends Endocrinol Metab; 2012 Nov; 23(11):576-81. PubMed ID: 22595550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
    Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
    J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydrodiconiferyl Alcohol Inhibits Osteoclast Differentiation and Ovariectomy-Induced Bone Loss through Acting as an Estrogen Receptor Agonist.
    Lee W; Ko KR; Kim HK; Lee DS; Nam IJ; Lim S; Kim S
    J Nat Prod; 2018 Jun; 81(6):1343-1356. PubMed ID: 29869503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen directly attenuates human osteoclastogenesis, but has no effect on resorption by mature osteoclasts.
    Sørensen MG; Henriksen K; Dziegiel MH; Tankó LB; Karsdal MA
    DNA Cell Biol; 2006 Aug; 25(8):475-83. PubMed ID: 16907645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression pattern of autophagy mediators in alveolar bone osteoclasts following estrogen withdrawal in female rats.
    Florencio-Silva R; Sasso GRDS; Sasso-Cerri E; Simões MJ; Cerri PS
    J Mol Histol; 2021 Apr; 52(2):321-333. PubMed ID: 33409945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
    Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
    J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.